Skip to main content

Marketing to Medicare or Medicaid Beneficiaries - What You Can and Cannot Do Course Duration

Compliance Key INC - Medical Device Training

Overview
Because the Anti-Kickback Statute is so broad it what it proscribes, healthcare organizations, conducting what would be normal marketing activities in other industries, have run afoul of the Statute on numerous occasions. The Statute and the regulations only tell part of the story. This program will review not only the Statute and its safe harbors, but will provide an in-depth overview of OIG guidance and advisory opinions dealing with marketing activities, as well as a review of case law regarding marketing behavior.
Why should you attend this webinar?
If your organization, be it a hospital, physician practice, DME provider, or any other provider offering healthcare services or supplies, engages in marketing its product or services, care must be taken to ensure that the organization does not run afoul of the Anti-Kickback Statute. This program will review not only the Statute itself, and the safe harbors, but will also critique the case law, OIG advisory opinions, and OIG compliance guidance to help you understand what you can and cannot do with engaging in healthcare marketing.
When you finish this program, you should have a good understanding of what you can and cannot do with regard to marketing activities. The penalties for not conducting a marketing program correctly can be severe, including exclusion, civil monetary penalties and even criminal prosecution.
Areas Covered in the Session:
  • A brief review of the Anti-Kickback Statute, what it is and what is prohibited.
  • A brief review of the safe harbors that relate to marketing activities.
  • A review of the OIG advisory opinions as they relate to marketing.
  • A review of OIG compliance guidance as it relates to marketing.
  • An overview of case law relating to marketing activities.
  • Strategies that should be taken to preclude liability.
Who can Benefit:
  • Hospital executives
  • Physicians, including dentists, podiatrists and chiropractors
  • Physician practice executives
  • DME provider executives
  • Ancillary service providers
  • Ancillary service provider executives
  • Attorneys representing any and all of the above

Comments

Popular posts from this blog

The 5 most Dangerous Risks Under New HIPAA Laws

Compliance Key  -   Online hipaa training for employees in US Overview This 90-minute webinar will be addressing how practice/business managers (or compliance offers) need to get their HIPAA house in order before the imminent audits occur. It will also address major changes under the Omnibus Rule and any other applicable updates for 2018. We will go into detail about the 5 biggest "gotcha's" related to compliance with this enigmatic law. I will also speak of multiple litigated cases I have been involved with involving HIPAA compliance (or lack there of areas also covered will be texting, email, encryption, medical messaging, voice data and risk factors as they relate to IT.  The primary goal is to ensure everyone is well educated on what is myth and what is reality with this law, there is so much misleading information regarding the do's and don'ts with HIPAA - I want to add clarity for compliance officers and what you guys need to do and how to best im...

Strategies for Becoming a Business Partner to Your Healthcare Leaders.Compliance Key INC -

Compliance Key INC  -  Healthcare Training Online                                                    Jay Anstine Mr. Anstine's professional background includes working on the provider and the payer side of the market, for large for-profit and non-profit health systems, and small physician-owned entities. In tackling the countless regulatory and operational issues for these diverse organization types, he has developed a deep understanding of the business of healthcare and the regulations that govern the industry.  Webinar Id:  LSHCSJA022  10:00 AM PT | 01:00 PM ET  12/13/2017  Duration 60 mins  Overview All too often compliance is seen as an obstacle or otherwise viewed negatively by healthcare leaders. This presentation will discuss strategies and insights to help the compliance of...

CMO Supplier Quality Agreements :- How to Comply with new FDA and EU Guidelines for Contract Drug Manufacturer

Compliance Key INC  -  Compliance Online Training                                             Roger Cowan Roger Cowan is the Keynote Spaker at Compliance Key Inc. He is the founder and owner of R Cowan Consulting Services LLC, a consulting company specializing primarily in the area of pharmaceutical contract manufacturing. He has 35 years experience in pharmaceutical quality assurance and manufacturing.  Webinar Id:  LSHCRC007  10:00 AM PT | 01:00 PM ET  12/07/2017  Duration 60 mins Overview A Quality Agreement is a contract between a pharmaceutical firm and a GMP Contract Manufacturer detailing the responsibilities of each party in assuring the quality, safety, and efficacy of the manufactured drug.  Recently, the EU and the FDA issued regulatory guidance to bring some clarity and consistenc...